bcbsil glp-1 coverage Why Blue Cross Blue Shield is rolling back of weight loss drugs in Massachusetts 2026 Pharmacy Benefits | Blue

For bloating and distension, a large meta-analysis of 82 trials found combination probiotics and Bacillus strains showed benefit, though the authors rated the overall certainty of evidence as low, so this is best framed as "some evidence," not a guarantee

2S306S312

This discovery led to the development of exenatide, which in 2005 became the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes (T2DM)

2b), suggesting that deficiency of SMARCA4, SMARCB1, and PBRM1 results in downregulation of SLC7A11, followed by a reduction in basal levels of GSH (which is consistent with the findings regarding ARID1A-deficiency) 15,16